AI Science Tracker

Korea Institute of Radiological and Medical Sciences

1 discovery from 2022

Discoveries

PCW-A1001, AI-assisted de novo design approach to design a selective inhibitor for FLT-3(D835Y) in acute myeloid leukemia.

Source check: Needs source check. Not independent scientific confirmation.

Finding / tested result: Generated candidates underwent further filtering and selection; biochemical measurements support differential mutant/wild-type inhibition. This is preclinical enzyme evidence.

Technology: LSTM recurrent generative neural network

Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.

AI contribution
LSTM recurrent generative neural network is the AI method documented in the editorial source review.
Limitation / still unknown
The date refers to the cited version. Earlier public versions and independent replication were not systematically verified.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://doi.org/10.3389/fmolb.2022.1072028

Needs source check · editorial details

The source has not been fully checked or contains conflicting information. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review scope and date are not recorded; source checked does not establish full-text review.

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 3/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open the interactive profile for the timeline, or browse all organizations and model families.